Five dimensions of age-related macular degeneration provide new insight

Five dimensions of age-related macular degeneration provide new insight
UAB's Christine Curcio, Ph.D., is a world-renowned AMD researcher. Credit: Steve Wood

A new study—published in Investigative Ophthalmology and Visual Science from University of Alabama at Birmingham researchers—suggests that linking to a fifth dimension for molecules and affected cells could help define new therapeutic strategies for those suffering from age-related macular degeneration.

Christine A. Curcio, Ph.D., White-McKee Endowed Professor in Ophthalmology with UAB's Department of Ophthalmology and Visual Sciences, says these findings could open new possibilities for patients with AMD.

"The retina is like the camera chip in a smartphone—it takes pictures for the brain," she said. "Each light-sensitive photoreceptor sits in a precise location (x,y) and connects to well-organized tissue layers (z). Because the front of the eye is clear, doctors can see retinal layers using optical coherence tomography."

This clinical tool is a quick and painless imaging test that uses to take pictures of the back of the eye. It is widely used to diagnose and manage age-related macular degeneration. AMD degrades detailed vision in older persons worldwide.

"With OCT, retina changes can be observed over time (t), giving four dimensions (x,y,z,t)," Curcio said. "Linking to a , (m), for molecules in affected cells, could help define new therapeutic strategies."

Much of the large AMD population currently lacks treatment options.

Curcio said bright spots in , called HRF, indicate a "high risk for" advanced AMD.

"In new research, investigators used OCT to watch HRF moving across the retina over months," Curcio said. "In a microscopic study of tissue specimens, scientists found that HRF corresponded to retinal pigment epithelium, or RPE, cells."

These cells, which normally support photoreceptors, left their layer, with some contacting remote blood vessels. Further, out-of-place RPE changed their molecular character; they no longer contained proteins needed directly for vision but instead contained proteins used by immune cells. This switch suggests epithelial-mesenchyme-transition. EMT is a well-known molecular process in .

"These research findings are important in suggesting that treatments already investigated for cancer might be beneficial for AMD," Curcio said. "Results also confirm the power of OCT, which doctors use daily, for seeing cellular activity and, ultimately, treatment responses in patients."

More information: Dongfeng Cao et al, Hyperreflective Foci, Optical Coherence Tomography Progression Indicators in Age-Related Macular Degeneration, Include Transdifferentiated Retinal Pigment Epithelium, Investigative Opthalmology & Visual Science (2021). DOI: 10.1167/iovs.62.10.34

Citation: Five dimensions of age-related macular degeneration provide new insight (2021, August 30) retrieved 20 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Researchers develop best-yet cell culture system for age-related macular degeneration


Feedback to editors